We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
An individualized, multivariable model can predict survival in patients with nonmetastatic prostate cancer (PCa), according to a study published online March 12 in PLOS Medicine.